Prostate Cancer - Results from #27660

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer - Abstract June 17, 2011

Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. - Abstract June 16, 2011

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: The relationship between dose-volume histogram parameters and the occurrence rate - Abstract June 16, 2011

Evaluation of polygenic risk scores for predicting breast and prostate cancer risk - Abstract June 16, 2011

Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): An interim analysis of toxicity and efficacy - Abstract June 16, 2011

Tumor markers in prostate cancer I: Blood-based markers - Abstract June 16, 2011

State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer - Abstract June 16, 2011

Benzyldihydroxyoctenone, a novel nonsteroidal antiandrogen, shows differential apoptotic induction in prostate cancer cells in response to their androgen responsiveness - Abstract June 16, 2011

A miRNA expression signature that separates between normal and malignant prostate tissues - Abstract June 16, 2011

Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer - Abstract June 16, 2011

Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: Technique and outcomes - Abstract June 16, 2011

Diagnosis and treatment of prostate cancer in renal-transplant recipients - Abstract June 15, 2011

Early detection of prostate cancer with emphasis on genetic markers - Abstract June 15, 2011

Role of histopathology and molecular markers in the active surveillance of prostate cancer - Abstract June 15, 2011

Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy - Abstract June 15, 2011

Study of the distribution of microvessels in normal and pathologic prostate using an information-based similarity analysis - Abstract June 15, 2011

Dynamic prediction of metastases after radical prostatectomy for prostate cancer - Abstract June 15, 2011

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: Results from a prospective phase II randomized trial - Abstract June 15, 2011

Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison - Abstract June 15, 2011

Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancer - Abstract June 15, 2011

Page 1384 of 1435